Senior Director - Therapy Development Mitral & Tricuspid Therapies

We anticipate the application window for this opening will close on - 11 Nov 2026   Careers that change lives start here. Medtronic is a global leader in healthcare technology with a Mission to alleviate pain, restore health, and extend life. Our 95,000 employees work across more than 150 countries to put patients first — developing innovative medical technologies that improve the lives of 72+ million patients each year. Your unique talents will help shape the future of healthcare while building a career grounded in purpose, growth, and impact. A Day in the Life The Structural Heart business is advancing innovative mitral and tricuspid therapies designed to address complex valvular heart disease. The Mitral & Tricuspid Therapy Development organization plays a critical role in supporting clinical-stage programs, generating physician and procedural insights, advancing evidence development, and preparing the organization for future commercialization. The team partners closely with Research & Development, Clinical, Regulatory, Medical Affairs, Marketing, Commercial, and Medical Education functions to support therapy adoption, physician training, and launch readiness across a growing portfolio. This role leads the U.S. Therapy Development organization and provides strategic leadership for global imaging and technical-support capabilities supporting mitral and tricuspid therapies. The position is responsible for building the capabilities, talent, operating models, and organizational readiness required to transition from clinical-stage support to a scalable commercial field organization. This position may be located anywhere within the United States and is designated as Remote. Travel up to 50% is required to support physician engagement, clinical sites, team leadership, and cross-functional business activities.                     The Senior Director, Therapy Development, Mitral & Tricuspid Therapies provides strategic and operational leadership for a field-based organization supporting clinical-stage mitral and tricuspid programs while preparing the business for future commercialization. This leader is accountable for clinical execution, physician engagement, field capability development, organizational readiness, and commercialization planning across a complex portfolio of structural heart therapies. Primary Responsibilities • Lead the U.S. Therapy Development organization supporting clinical trial execution, physician engagement, procedural success, and customer support across mitral and tricuspid programs. • Provide strategic leadership for global imaging and technical-support teams responsible for patient evaluation, procedural planning, physician education, and therapy development. • Represent Therapy Development on Mitral and Tricuspid New Product Development core teams, influencing field capability requirements, physician adoption strategies, and commercialization readiness plans. • Develop and execute organizational transformation strategies that evolve Therapy Development from a clinical-stage support model into a scalable commercial field organization. • Partner with Clinical, Research & Development, Regulatory, Quality, Medical Affairs, Marketing, Commercial, and Medical Education leaders to align therapy, evidence-generation, and launch-readiness objectives. • Direct physician engagement strategies and translate clinical, imaging, and procedural insights into product-development priorities, training programs, and customer-support models. • Drive launch-readiness planning, including field organization design, talent strategies, training frameworks, resource planning, and customer adoption initiatives. • Lead organizational planning, investment recommendations, risk management, and execution against portfolio priorit